Sign in
or Register nowSchizophreniaConnection.com
Drug Treatment For Schizophrenia
Risperdal approved for kids
October 03, 2008
Expert & Community Posts
A New Indication for Abilify
By Paul Ballas , Health ExpertRecently, the medication Abilify (aripiprazole) was approved by the FDA for the... Read more »
Drug Prices - Part I
By Robin Cunningham , Health ExpertBefore you read this, I must confess that I have a relative who works for a major pharmaceutical... Read more »
Targeted Treatment for Schizophrenia Announced
By Jerry Kennard , Health ExpertOne of the first targeted treatments for schizophrenia has been announced in this month's American... Read more »
FDA Approves Risperdal for Children and Adolescents - a Good Move?
By Teri Robert , Health ExpertToday, the FDA approved Risperdal for the treatment of schizophrenia in adolescents 13 to 17... Read more »
New Research in Schizophrenia Treatment
By Robin Cunningham , Health ExpertBeing a biological scientist by training with graduate work in psychology, and having developed... Read more »
Health Guide
Schizophrenia: Introduction
In 2007, the Food and Drug Administration approved risperidone (Risperdal) and aripiprazole (Abilify) for treatment schizophrenia in teenagers. These drugs are the first... Read more »Schizophrenia: Treatment
...generally used for schizophrenia:Typical antipsychotics. Until recently, these drugs were the mainstay treatments for schizophrenia. They include haloperidol (Haldol), chlorpromazine (Thorazine),... Read more »Schizophrenia: References
ReferencesAleman A, Sommer IE, Kahn RS. Efficacy of slow repetitive transcranial magnetic stimulation in the treatment of resistant auditory hallucinations in schizophrenia: a meta-analysis. J Clin... Read more »Schizophrenia: Diagnosis
The doctor will use one or more verbal screening tests to help determine whether a patient's symptoms meet the criteria for schizophrenia. Because no single symptom is specific to... Read more »Schizophrenia: Other Treatments
Other TreatmentsElectroconvulsive therapy (ECT), often called shock treatment, has received bad press since it was introduced in the 1940s. However, refined techniques have revived its use,... Read more »Images
Related News
New schizophrenia drug shows promise in new study
October 28, 2008A new drug called asenapine has shown positive results in a new clinical trial, its maker has reported. According to a news release from drugmaker... Read summary »
FDA approves new schizophrenia drug
May 09, 2009The U.S. Food and Drug Administration (FDA) has approved a new drug called Fanapt for the treatment of schizophrenia. FDA officials say Fanapt will... Read summary »
Antipsychotic Drug Causes Weight Gain
February 22, 2007By Lucy Williams, Ivanhoe Health Correspondent ORLANDO, Fla. (Ivanhoe Newswire) -- Some patients undergoing treatment for mental illness gain so... Read summary »
Invega OK'ed to treat schizophrenia
October 02, 2008The Food and Drug Administration (FDA) has approved extended-release Invega for the treatment of schizophrenia. The FDA made the decision after... Read summary »
Once-a-day Seroquel goes to FDA for approval
October 02, 2008Drugmaker AstraZeneca is seeking approval from the Food and Drug Administration for a once-daily formula of Seroquel. Seroquel is currently approved... Read summary »
- Privacy Policy: Updated as of April 1, 2009|
- Service Terms and Agreement|
- Advertising Policy|
- Contact Us|
- About Us|
- RSS Feed|
- Site Map|
- How to Use This Site
By using this service, you accept our Terms of Use. Please read them. The consumer health information on SchizophreniaConnection.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.
 | We comply with the HONcode standard for trustworthy health information: verify here. |
